About QIBA: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
| Line 5: | Line 5: | ||
'''RSNA’s Quantitative Imaging Biomarkers Alliance (QIBA®) stakeholders include''': | '''RSNA’s Quantitative Imaging Biomarkers Alliance (QIBA®) stakeholders include''': | ||
*clinical research community | |||
*imaging equipment manufacturers | |||
*pharmaceutical industry | |||
*government agencies | |||
*medical informatics companies | |||
'''QIBA stakeholders ensure quantitative imaging results are:''' | '''QIBA stakeholders ensure quantitative imaging results are:''' | ||
*Consistent | |||
*Achievable | |||
*Reliable | |||
*Validated | |||
| Line 21: | Line 21: | ||
'''QI develops, standardizes, and optimizes:''' | '''QI develops, standardizes, and optimizes:''' | ||
*Anatomical, functional, and molecular imaging acquisition protocols | |||
*Data analyses | |||
*Display methods | |||
*Reporting structures | |||
Revision as of 18:16, 19 November 2021
WHO IS QIBA®?
RSNA’s Quantitative Imaging Biomarkers Alliance (QIBA®) stakeholders include:
- clinical research community
- imaging equipment manufacturers
- pharmaceutical industry
- government agencies
- medical informatics companies
QIBA stakeholders ensure quantitative imaging results are:
- Consistent
- Achievable
- Reliable
- Validated
THE IMPORTANCE OF QUANTITATIVE IMAGING (QI)
QI develops, standardizes, and optimizes:
- Anatomical, functional, and molecular imaging acquisition protocols
- Data analyses
- Display methods
- Reporting structures